Krystal Biotech Inc (KRYS) returns
Krystal Biotech returns over 5 years
$1,000 invested in Krystal Biotech five years ago was worth $6,634 at the close on October 30, 2026, with dividends reinvested: an average return of 46.0% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -0.1% | — | $999.19 | -0.9% |
| 3 months | -9.4% | — | $905.79 | +2.1% |
| Year to date | +34.8% | — | $1,348 | +11.7% |
| 1 year | +75.7% | — | $1,757 | +12.4% |
| 3 years | +185.5% | +41.9% | $2,855 | +88.5% |
| 5 years | +563.4% | +46.0% | $6,634 | +76.0% |
Krystal Biotech return by calendar year
| Year | KRYS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +34.8% | +11.7% | +23.1% |
| 2025 | +57.4% | +17.7% | +39.7% |
| 2024 | +26.3% | +24.9% | +1.4% |
| 2023 | +56.6% | +26.2% | +30.4% |
| 2022 | +13.3% | -18.2% | +31.4% |
| 2021 | +16.6% | +28.7% | -12.2% |
| 2020 | +8.3% | +18.4% | -10.0% |
| 2019 | +166.5% | +31.2% | +135.3% |
| 2018 | +97.5% | -4.6% | +102.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: KRYS financials · KRYS valuation
No forecast, no recommendation. This page describes Krystal Biotech Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.